These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3420155)

  • 1. d-amphetamine and active behavior--induced changes of regional brain ascorbic acid levels in the rat.
    Desole MS; Miele M; Demontis P; Carboni F; Senini A; Esposito G; Anania V
    Pharmacol Res Commun; 1988 Jun; 20(6):499-509. PubMed ID: 3420155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical and behavioural changes induced by ascorbic acid and d-amphetamine in the rat.
    Desole MS; Anania V; Esposito G; Carboni F; Senini A; Miele E
    Pharmacol Res Commun; 1987 Jun; 19(6):441-50. PubMed ID: 3659117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the mechanism of d-amphetamine-and apomorphine-induced changes of ascorbic acid catabolism in discrete brain areas of the rat.
    Desole MS; Miele M; Esposito G; Enrico P; De Natale G; Miele E
    Pharmacol Res; 1991 Apr; 23(3):295-306. PubMed ID: 2068053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine cumulation and tolerance development: concurrent and opposing phenomena.
    Sparber SB; Fossom LH
    Pharmacol Biochem Behav; 1984 Mar; 20(3):415-24. PubMed ID: 6709676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of nicotine and (+)-amphetamine on rat behaviour in an unsignalled Sidman avoidance schedule.
    Balfour DJ
    J Pharm Pharmacol; 1990 Apr; 42(4):257-60. PubMed ID: 1974293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
    Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
    J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some effects of prenatal exposure to d-amphetamine sulfate and phenobarbital on developmental neurochemistry and on behavior.
    Zemp JW; Middaugh LD
    Addict Dis; 1975; 2(1-2):307-31. PubMed ID: 1163369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective pharmacological changes of regional ascorbic acid metabolism in the brain].
    Miele M; Desole MS; Enrico P; Miele E
    Clin Ter; 1990 Sep; 134(6):345-53. PubMed ID: 2149531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal locomotor and long-term behavioral effects of d-amphetamine in the rat.
    Sobrian SK; Weltman M; Pappas BA
    Dev Psychobiol; 1975 May; 8(3):241-50. PubMed ID: 1230342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between d-amphetamine and alpha-methyltyrosine in rat shuttle-box behavior.
    Rech RH; Moore KE
    Brain Res; 1968 May; 8(2):398-400. PubMed ID: 5652733
    [No Abstract]   [Full Text] [Related]  

  • 11. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.
    Hertel P; Mathé JM; Nomikos GG; Iurlo M; Mathé AA; Svensson TH
    Behav Brain Res; 1995 Dec; 72(1-2):103-14. PubMed ID: 8788863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cortical ablation on d-amphetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat.
    Desole MS; Miele M; Enrico P; Fresu L; Esposito G; De Natale G; Miele E
    Neurosci Lett; 1992 May; 139(1):29-33. PubMed ID: 1407680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.
    Miele M; Mura MA; Enrico P; Esposito G; Serra PA; Migheli R; Zangani D; Miele E; Desole MS
    Br J Pharmacol; 2000 Feb; 129(3):582-8. PubMed ID: 10711358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats.
    Stroemer RP; Kent TA; Hulsebosch CE
    Stroke; 1998 Nov; 29(11):2381-93; discussion 2393-5. PubMed ID: 9804653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of luteinizing hormone releasing hormone (LHRH) on the behavioral effects of amphetamine in rats.
    Mora S; Díaz-Véliz G
    Pharmacol Biochem Behav; 1983 Aug; 19(2):157-61. PubMed ID: 6356168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of tail-pressure stress and d-amphetamine in disruption of the rat's ability to ignore an irrevelant stimulus.
    Hellman PA; Crider A; Solomon PR
    Behav Neurosci; 1983 Dec; 97(6):1017-21. PubMed ID: 6651958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amphetamine and haloperidol on avoidance behavior and exploratory activity.
    Kovács GL; de Wied D
    Eur J Pharmacol; 1978 Dec; 53(1):103-7. PubMed ID: 738353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adriamycin and of d-amphetamine on endogenous levels of ascorbic acid in rodents.
    Miele M; Desole MS; Demontis MP; Enrico P; De Natale G; Varoni MV; Anania V
    Pharmacol Res; 1989; 21 Suppl 1():13-4. PubMed ID: 2633163
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine.
    White LK; Maurer M; Kraft ME; Oh C; Rebec GV
    Pharmacol Biochem Behav; 1990 Jul; 36(3):485-9. PubMed ID: 2377651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.